Vir
VIR is a biotechnology company that engages in developing and commercializing drugs for serious infectious diseases.
Business Model:
Revenue: $284.4M
Employees: 201-500
Industries / Tags:
Detailed Vir Information
Geographic Data
Address: 499 Illinois Street
City: San Francisco
State: CA
Zip: 94158
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$250M
Raised Total:$491M
Social
Metrics
1,910,221Website Global Rank
11,327Website Monthly Traffic
Twitter Followers
Description
VIR is a biotechnology company that engages in developing and commercializing drugs for serious infectious diseases.
Contact Phone:
+14159064324
Contact Email:
Vir went public on 10/10/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/10/2019
IPO Valuation:
$2B
Ticker Symbol:
VIR
IPO Price:
$20/share
Amount Raised:
$143M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Equity | $66M | 5/2020 | Equity | $32.4M | 10/2019 | IPO | $143M |
|
8/2018 | Series A | $66M | 1/2019 | Series B | 3 | $327.6M |
ARCH Venture Partners Alta Partners SoftBank Vision Fund SoftBank Vision Fund ARCH Venture Partners Alta Partners SoftBank Vision Fund SoftBank Vision Fund |
4/2020 | Post-IPO Equity | 1 | $250M |
GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline |
1/2017 | Venture Round | 5 | $150M |
Alta Partners ARCH Venture Partners Bill &a; Melinda Gates Foundation SoftBank Vision Fund Altitude Life Science Ventures ARCH Venture Partners Bill &a; Melinda Gates Foundation Alta Partners ARCH Venture Partners Bill &a; Melinda Gates Foundation SoftBank Vision Fund Altitude Life Science Ventures ARCH Venture Partners Bill &a; Melinda Gates Foundation |
1/2017 | Equity | - | 1/2017 | Equity | - |
ARCH Venture Partners Bill & Melinda Gates Foundation ARCH Venture Partners Bill & Melinda Gates Foundation |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2018 | Agenovir Corporation | |
| 9/2017 | Humabs | |
| 1/2017 | TomegaVax |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
